6.24
Hepatic Drug Clearance: Effect of Protein Binding
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited…
Hepatic clearance can be affected by protein binding based on the extraction ratio of the drug.
Drugs with high extraction ratios are flow-limited and unaffected by protein binding during hepatic clearance.
Drugs with low extraction ratios may be influenced by plasma protein binding, but the impact depends on the fraction of drug bound.
For low extraction ratio drugs that are less than 80% protein-bound, small changes in protein binding have minimal effects on hepatic clearance. These drugs are considered capacity-limited and binding-insensitive.
However, those that are highly bound to plasma protein are considered capacity-limited and binding-sensitive. Small changes in protein binding can cause a significant increase in the free drug concentration, leading to an increased drug metabolism rate and hepatic clearance.
Any drug metabolized and eliminated by the liver can be classified by plotting on a triangular graph based on its extraction ratio and percent of plasma protein binding.
View the full transcript and gain access to JoVE Core videos
Q1: How does extraction ratio determine whether protein binding affects hepatic drug clearance?
Drugs with high extraction ratios are flow-limited and unaffected by protein binding during hepatic clearance. Conversely, drugs with low extraction ratios may be influenced by plasma protein binding, though the impact depends on the fraction of drug bound. This classification helps predict how changes in protein binding will affect a drug's hepatic metabolism.
Q2: What is the difference between binding-sensitive and binding-insensitive drugs in hepatic clearance?
Low extraction ratio drugs less than 80% protein-bound are capacity-limited and binding-insensitive, meaning small changes in protein binding have minimal effects on hepatic clearance. Highly protein-bound drugs are capacity-limited and binding-sensitive, where even slight alterations in protein binding significantly increase free drug concentration, elevating metabolism rate and hepatic clearance.
Q3: Why does propranolol's hepatic clearance depend primarily on liver blood flow?
Propranolol has a high hepatic extraction ratio and relatively low plasma protein binding, classifying it as flow-limited. This means its hepatic clearance depends mainly on liver blood flow rather than enzyme activity or protein binding. Changes in liver perfusion significantly affect propranolol's metabolism and elimination from the body.
Q4: How does warfarin's position on the triangular graph explain its clearance characteristics?
Warfarin has a low hepatic extraction ratio and high plasma protein binding, placing it near the capacity-limited, binding-sensitive corner of the triangular graph. For warfarin, hepatic clearance is influenced more by plasma protein binding and enzyme activity than by liver blood flow, making it sensitive to changes in protein binding and metabolic capacity.
Q5: What does the triangular graph reveal about drug metabolism and hepatic elimination?
The triangular graph categorizes drugs by plotting hepatic extraction ratio against percent plasma protein binding. Any drug metabolized and eliminated by the liver can be classified on this graph, revealing whether clearance is flow-limited, capacity-limited and binding-insensitive, or capacity-limited and binding-sensitive. This framework predicts how liver disease affects drug disposition.
Q6: How does liver disease affect drugs with different extraction ratios and protein binding profiles?
Propranolol's clearance may decrease due to reduced blood flow in liver disease, while warfarin's clearance may change due to alterations in protein binding or enzyme activity. Understanding a drug's position on the triangular graph helps predict its behavior during hepatic dysfunction, enabling clinicians to anticipate disposition changes.
Q7: What causes significant changes in free drug concentration for highly protein-bound drugs?
For capacity-limited, binding-sensitive drugs, small changes in plasma protein binding can cause substantial increases in free drug concentration. This occurs because a larger fraction of the drug becomes unbound and available for metabolism. The increased free drug concentration leads to elevated drug metabolism rate and enhanced hepatic clearance.